Current Research
May 17th, 2024 (Initiation)
ASX:WNX
Wellnex Life Limited
Revised Financial Projections and Valuation Outlook
View Initiation Report![Revised Financial Projections and Valuation Outlook Research Report (ASX:WNX)](https://cache.mawsongraham.com.au/file/mawson-graham/images/companies/1380-5e446f25.jpg)
![Long term SUAS contract secured Research Report (ASX:XTE)](https://cache.mawsongraham.com.au/file/mawson-graham/images/companies/1359-8d5467f9.jpg)
August 29th, 2019 (Initiation)
ASX:VRS
Veris Ltd
Long term potential top line and margin improvement
View Initiation Report![Long term potential top line and margin improvement Research Report (ASX:VRS)](https://cache.mawsongraham.com.au/file/mawson-graham/images/companies/1321-4cc02daf.jpg)
![New Lyramid CEO Appointment Research Report (ASX:CDY)](https://cache.mawsongraham.com.au/file/mawson-graham/images/companies/275-71a87fd3.jpg)
![HighCom Acquisition and Revenue Momentum Research Report (ASX:XTE)](https://cache.mawsongraham.com.au/file/mawson-graham/images/companies/1359-55111dcc.jpg)
May 10th, 2019 (Initiation)
ASX:CDY
Cellmid Ltd
Multiple Near Term Growth Triggers
View Initiation Report![Multiple Near Term Growth Triggers Research Report (ASX:CDY)](https://cache.mawsongraham.com.au/file/mawson-graham/images/companies/275-5580e183.jpg)
March 6th, 2019 (Initiation)
ASX:XTE
Xtek Ltd
High growth potential via proprietary tech commercialisation and a reduced risk profile from contracted revenues.
View Initiation Report![High growth potential via proprietary tech commercialisation and a reduced risk profile from contracted revenues. Research Report (ASX:XTE)](https://cache.mawsongraham.com.au/file/mawson-graham/images/companies/1359-3924cb16.jpg)